Happy Mommy! Happy Baby! Study

NCT ID: NCT01700374

Last Updated: 2023-01-06

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1506 participants

Study Classification

OBSERVATIONAL

Study Start Date

2012-08-31

Study Completion Date

2022-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine how difficult life-events that women experienced during their childhood might affect their babies.

Women who are asked to participate in this study will fill out forms about their physical and mental health, have 3D ultrasounds of their baby's adrenal gland, have their stress responses measured and have their baby's development and stress responses assessed.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this study are to further our understanding of maternal prepubertal adversity on fetal and infant neuroendocrine development. This study utilizes 3-D ultrasound to measure fetal adrenal gland volume, a battery of psychosocial/behavioral assessments to determine the degree of maternal stress and prepubertal adversity, and an acoustic startle paradigm and Trier Social Stress Test (TSST) to assess maternal arousal. This study also utilizes an infant stress test to assess infant arousal.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pregnancy Stress, Psychological Stress, Physiological Maternal-fetal Relations

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Women without Prepubertal Adversity

At 8-17 weeks gestational age, 1,500 pregnant women will complete:

* Adverse Childhood Events (ACE) Questionnaire;
* Perceived Stress Scale (PSS);
* A general health and demographic questionnaire.

All women who are screened will be asked if they would be willing to allow the study team to access their delivery report.

Women who report 0 or 1 adverse childhood experiences will be invited to continue in the study as part of the Women without Prepubertal Adversity cohort. We aim to have 125 women in this cohort.

No interventions assigned to this group

Women with Prepubertal Adversity

At 8-17 weeks gestational age, 1,500 pregnant women will complete:

* Adverse Childhood Events (ACE) Questionnaire;
* Perceived Stress Scale (PSS);
* A general health and demographic questionnaire.

All women who are screened will be asked if they would be willing to allow the study team to access their delivery report.

Women who report 2 or more adverse childhood experiences will be invited to continue in the study as part of the Women without Prepubertal Adversity cohort. We aim to have 125 women in this cohort.

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Aged 18 to 45 years;
* Able to give written informed consent;
* Between 8 to 17 weeks at time of recruitment;
* Attendance at 20 week ultrasound at a UPHS site;
* Healthy full term (35 6/7 weeks) infants;
* Fluency in written and spoken English.

Exclusion Criteria

* Presence of a known abnormality in the present fetus, twin pregnancy or a multiple pregnancy;
* Presence of a serious medical or neurological illness, requiring treatment during pregnancy;
* Use of an antipsychotic or antidepressant medication anytime within 2 months prior to the last menstrual period;
* Drug or alcohol abuse history within previous 2 years;
* Life-time history of psychotic disorder including, schizophrenia, schizoaffective disorder; major depression with psychotic features and bipolar disorder
* Active psychiatric illness requiring treatment based upon the clinical judgement of the study psychiatrist;
* Hamilton Depression Rating Scale Score \> 14;
* Suicidal ideation within the previous 6 months;
* Use of steroids drugs of antihypertensives during pregnancy as they could alter physiologic arousal;
* A history of preterm birth or history of preterm labor in the active pregnancy.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

National Institute of Mental Health (NIMH)

NIH

Sponsor Role collaborator

University of Pennsylvania

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Cynthia N Epperson, M.D.

Role: PRINCIPAL_INVESTIGATOR

University of Pennsylvania

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

3701 Market Street

Philadelphia, Pennsylvania, United States

Site Status

Helen O. Dickens Center for Women's Health, Hospital of the University of Pennsylvania

Philadelphia, Pennsylvania, United States

Site Status

Penn Center for Women's Behavioral Wellness

Philadelphia, Pennsylvania, United States

Site Status

Penn Medicine Washington Square (PMWS)

Philadelphia, Pennsylvania, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

References

Explore related publications, articles, or registry entries linked to this study.

Morrison KE, Epperson CN, Sammel MD, Ewing G, Podcasy JS, Hantsoo L, Kim DR, Bale TL. Preadolescent Adversity Programs a Disrupted Maternal Stress Reactivity in Humans and Mice. Biol Psychiatry. 2017 Apr 15;81(8):693-701. doi: 10.1016/j.biopsych.2016.08.027. Epub 2016 Aug 26.

Reference Type RESULT
PMID: 27776734 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

P50MH099910

Identifier Type: NIH

Identifier Source: secondary_id

View Link

812880

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Antimanic Drug Use in Pregnancy
NCT00585702 COMPLETED
Mindfulness in High Risk Pregnancies
NCT04496115 NOT_YET_RECRUITING NA
Mindful Moms Randomized Control Trial
NCT04886856 RECRUITING NA